UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Characteristics and Surgical Outcomes in Very Elderly Patients (≥75 years) with Renal Cell Carcinoma: Data from the Latin American Renal Cancer Group

Revista de investigacion clinica, 2020-09, Vol.72 (5), p.308-315

2020

Volltextzugriff (PDF)

Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens

Journal for immunotherapy of cancer, 2020-06, Vol.8 (1), p.e000704

2020

Volltextzugriff (PDF)

Manic Fringe deficiency imposes Jagged1 addiction to intestinal tumor cells

Nature communications, 2018-07, Vol.9 (1), p.2992-13, Article 2992

2018

Volltextzugriff (PDF)

T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates

Gene therapy, 2016-10, Vol.23 (10), p.753-759

2016

Volltextzugriff (PDF)

Predictive score of success adapted to our environment to improve results of extracorporeal lithotripsy

Archivos españoles de urología, 2016-09, Vol.69 (7), p.398

2016

Volltextzugriff (PDF)

The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative

International journal of molecular sciences, 2016-02, Vol.17 (3), p.313-313

2016

Volltextzugriff (PDF)

1163 EDA-STREPTAVIDIN FUSION PROTEIN CONJUGATED TO BIOTINYLATED HCV-NS3 PROTEIN INDUCES STRONG T CELL IMMUNE RESPONSES AGAINST NS3

Journal of hepatology, 2013-04, Vol.58, p.S473-S473

2013

Volltextzugriff (PDF)

883 VACCINATION AGAINST HEPATITIS C VIRUS WITH A RECOMBINANT FUSION PROTEIN CONTAINING THE EXTRA DOMAIN A FROM FIBRONECTIN AND THE HEPATITIS C VIRUS NS3 PROTEIN

Journal of hepatology, 2009, Vol.50, p.S321-S321

2009

Volltextzugriff (PDF)

SCHU-19: Results of a Conservative Approach in Pyeloureteral Tumors

Urology (Ridgewood, N.J.), 2008, Vol.72 (5), p.S8-S9

2008

Volltextzugriff (PDF)

SCHU-20: E-Cadherin Predictive Value for Recurrence of Bladder Noninvasive Tumors (Ta-T1)

Urology (Ridgewood, N.J.), 2008, Vol.72 (5), p.S9-S9

2008

Volltextzugriff (PDF)

Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40

Antiviral research, 2007-04, Vol.74 (1), p.25-35

2007

Volltextzugriff (PDF)

[472] INDUCTION OF POTENT AND LONG LASTING CD4 AND CDS T-CELL RESPONSES AGAINST HEPATITIS C VIRUS BY IMMUNIZATION WITH VIRAL ANTIGENS PLUS POLY(I:C) AND ANTI-CD40

Journal of hepatology, 2007, Vol.46, p.S179-S179

2007

Volltextzugriff (PDF)

El potencial de la inmunomodulación con anticuerpos monoclonales anti-CD137 (4-1BB) para terapia de enfermedades malignas e infecciones virales crónicas

Anales del sistema sanitario de Navarra, 2006-04, Vol.29 (1), p.77-96

2006

Volltextzugriff (PDF)

Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus

Vaccine, 2005-05, Vol.23 (27), p.3493-3499

2005

Volltextzugriff (PDF)

HLA-A0201 specific immunogenicity of modified vaccinia virus Ankara (MVA) produced hepatitis C virus antigens -: Advantage of heterologous prime boost vaccination

HEPATOLOGY, 2004, Vol.40 (4), p.733A

2004

Volltextzugriff (PDF)

387 Protection against infection with an HCV-recombinant vaccinia virus by vaccination with an adenoviral vector enconding hepatitis C virus (HCV) NS4A protein

Journal of hepatology, 2004, Vol.40, p.115-116

2004

Volltextzugriff (PDF)

CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination

The Journal of immunology (1950), 2003-12, Vol.171 (11), p.5931-5939

2003

Volltextzugriff (PDF)

Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses

Journal of Virology, 2003-10, Vol.77 (20), p.10862-10871

2003

Volltextzugriff (PDF)

Expression of core and E1 proteins from hepatitis C virus in dendritic cells impairs T cell induction in vivo

Journal of hepatology, 2003-04, Vol.38, p.15-15

2003

Volltextzugriff (PDF)

Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus

Journal of hepatology, 2003-04, Vol.38, p.109-109

2003

Volltextzugriff (PDF)

A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine induced liver damage: A possible mechanism for viral persistence

Journal of hepatology, 2003-04, Vol.38, p.9-9

2003

Volltextzugriff (PDF)

A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine-induced liver damage

Hepatology (Baltimore, Md.), 2003-02, Vol.37 (2), p.461-470

2003

Volltextzugriff (PDF)

CD4 super(+)/CD25 super(+) Regulatory Cells Inhibit Activation of Tumor-Primed CD4 super(+) T Cells with IFN- gamma -Dependent Antiangiogenic Activity, as well as Long-Lasting Tumor Immunity Elicited by Peptide Vaccination

The Journal of immunology (1950), 2003-01, Vol.171 (11), p.5931-5939

2003

Volltextzugriff (PDF)

Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus

Vaccine, 2002-12, Vol.21 (3), p.202-210

2002

Volltextzugriff (PDF)

Pyogenous hepatic abscess treated by resection

Revista espanola de las enfermedades del aparato digestivo, 1987-05, Vol.71 (5), p.441

1987

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(12)
Life Sciences & Biomedicine
(11)
Animals
(9)
Mice
(8)
Humans
(7)
Mice, Inbred Balb C
(6)
Female
(5)
Immunology
(5)
Virology
(5)
Biological And Medical Sciences
(4)
Cd4-Positive T-Lymphocytes - Immunology
(4)
Hepacivirus - Immunology
(4)
Hepatitis C Virus
(4)
Vaccination
(4)
Adenoviridae - Genetics
(3)
Cd8-Positive T-Lymphocytes - Immunology
(3)
Gastroenterology And Hepatology
(3)
Hepatitis
(3)
Human Viral Diseases
(3)
Immunization
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Characteristics and Surgical Outcomes in Very Elderly Patients (≥75 years) with Renal Cell Carcinoma: Data from the Latin American Renal Cancer Group

Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens

Manic Fringe deficiency imposes Jagged1 addiction to intestinal tumor cells

T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates

Predictive score of success adapted to our environment to improve results of extracorporeal lithotripsy

The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative

1163 EDA-STREPTAVIDIN FUSION PROTEIN CONJUGATED TO BIOTINYLATED HCV-NS3 PROTEIN INDUCES STRONG T CELL IMMUNE RESPONSES AGAINST NS3

883 VACCINATION AGAINST HEPATITIS C VIRUS WITH A RECOMBINANT FUSION PROTEIN CONTAINING THE EXTRA DOMAIN A FROM FIBRONECTIN AND THE HEPATITIS C VIRUS NS3 PROTEIN

SCHU-19: Results of a Conservative Approach in Pyeloureteral Tumors

SCHU-20: E-Cadherin Predictive Value for Recurrence of Bladder Noninvasive Tumors (Ta-T1)

Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40

[472] INDUCTION OF POTENT AND LONG LASTING CD4 AND CDS T-CELL RESPONSES AGAINST HEPATITIS C VIRUS BY IMMUNIZATION WITH VIRAL ANTIGENS PLUS POLY(I:C) AND ANTI-CD40

El potencial de la inmunomodulación con anticuerpos monoclonales anti-CD137 (4-1BB) para terapia de enfermedades malignas e infecciones virales crónicas

Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus

HLA-A0201 specific immunogenicity of modified vaccinia virus Ankara (MVA) produced hepatitis C virus antigens -: Advantage of heterologous prime boost vaccination

387 Protection against infection with an HCV-recombinant vaccinia virus by vaccination with an adenoviral vector enconding hepatitis C virus (HCV) NS4A protein

CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination

Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses

Expression of core and E1 proteins from hepatitis C virus in dendritic cells impairs T cell induction in vivo

Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus

A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine induced liver damage: A possible mechanism for viral persistence

A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine-induced liver damage

CD4 super(+)/CD25 super(+) Regulatory Cells Inhibit Activation of Tumor-Primed CD4 super(+) T Cells with IFN- gamma -Dependent Antiangiogenic Activity, as well as Long-Lasting Tumor Immunity Elicited by Peptide Vaccination

Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus

Pyogenous hepatic abscess treated by resection

Suchergebnisse filtern